27 January 2022 in Proceedings of the National Academy of Sciences
Significance: Lineage analysis is an important assay for developmental biology, cancer biology, etc. Traditional tools in this field are time consuming, technically challenging, and in demand of preexisting knowledge. By integrating exogenous barcodes into cells, single-cell RNA-sequencing (scRNA-seq) can be used to conduct such tasks, but these assays required significant expertise in both wet- and dry-laboratory experiments. We developed a user-friendly algorithm to conduct cell-lineage inference solely based on endogenous markers of label-free scRNA-seq. This algorithm is able to identify lineage-informative mutations from a bunch of interfering mitochondrial RNA variants with high accuracy and efficiency. With this algorithm, we removed most of the technical hurdles of lineage analysis on scRNA-seq and will dramatically accelerate its application in biological research.
19 September 2023 in Proceedings of the National Academy of Sciences
Single-cell RNA-seq (scRNA-seq) analysis of multiple samples separately can be costly and lead to batch effects. Exogenous barcodes or genome-wide RNA mutations can be used to demultiplex pooled scRNA-seq data, but they are experimentally or computationally challenging and limited in scope. Mitochondrial genomes are small but diverse, providing concise genotype information. We developed “mitoSplitter,” an algorithm that demultiplexes samples using mitochondrial RNA (mtRNA) variants, and demonstrated that mtRNA variants can be used to demultiplex large-scale scRNA-seq data. Using affordable computational resources, mitoSplitter can accurately analyze 10 samples and 60,000 cells in 6 h. To avoid the batch effects from separated experiments, we applied mitoSplitter to analyze the responses of five non-small cell lung cancer cell lines to BET (Bromodomain and extraterminal) chemical degradation in a multiplexed fashion. We found the synthetic lethality of TOP2A inhibition and BET chemical degradation in BET inhibitor-resistant cells. The result indicates that mitoSplitter can accelerate the application of scRNA-seq assays in biomedical research.
1 March 2022 in SCIENTIA SINICA Vitae
生物医药研究主要依赖动物模型及人源细胞系,但是这些研究系统往往不能模拟人类个体发育过程、疾病发生机制和药物反应,因此导致在向临床转化方面遇到极大的困难。类器官是能模拟体内器官结构和功能特征的体外3D细胞簇。本文讨论了肝脏类器官的种类及来源方式,包括多能干细胞分化、成体干细胞分化及成纤维细胞转分化;同时概括了肝脏类器官在疾病建模、药物反应及毒性测试及再生医学等方面的应用。
14 September 2021 in Small Methods
Inside Front Cover In article number 2100206, Yang, Li, Huang, and co-workers designed an interactive web-based tool: LINT-web that demonstrates a novel intra-omics strategy to analyze multi-omics da...